ImmunityBio, Inc. Common Stock (NASDAQ: IBRX) last traded at $7.79, down 0.64% on the session. The quote above updates while this page is open; the figures below are drawn from ImmunityBio, Inc. Common Stock’s own filings and are restated only when a new one is published.
ImmunityBio, Inc. Common Stock trades on NASDAQ under the ticker IBRX. Its market capitalisation is $8.26 billion.
Valuation measures for ImmunityBio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $8.26B |
|---|---|
| Enterprise value | $9.85B |
| Price / sales | 49.80 |
| Beta | 1.56 |
Trailing-twelve-month figures tagged in ImmunityBio, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $165.79M |
|---|---|
| Net income (TTM) | -$992.35M |
| EPS (TTM) | -$0.970 |
| Operating margin | -151.88% |
| Cash | $75.67M |
Range and volume for IBRX over the past 52 weeks.
| 52-week high | $12.43 |
|---|---|
| 52-week low | $1.95 |
| Volume | 7.50M |
| Average volume | 11.20M |
| Previous close | $7.84 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.